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Abstract : 
         Purpose: The purpose of this study was to optimize and characterize the controlled release microspheres 
of Aceclofenac using “Box-Behnken experimental design”. The microspheres were prepared by using the 
natural polymer chitosan in different ratios with glutraldehyde as the cross linking agent.  Method: The 
microspheres were prepared by ionic cross linking technique. The microspheres were evaluated for particle size, 
drug content, drug loading efficiency, in vitro drug release surface morphology. Results and Conclusions: The 
particle size of the prepared microspheres was between 3 to 800µm in diameter. In conclusion NSAID 
controlled release delivery system utilizing natural polymer i.e; chitosan was successfully developed. Further 
parameters for dosage form designing can be identified for optimum formulation in terms of desirable long term 
stability and to study the therapeutic effects of these particles in vivo.   
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Introduction  
              The basic concept in the design of oral controlled release drug delivery is that the availability of drug 
depends on the kinetics of the drug release rather than drug absorption. Aceclofenac is a non steroidal anti-
inflammatory drug (NSAID) used to relieve pain and inflammation in rheumatoid arthritis, osteo arthritis and 
ankylosing spondilitis. The shorter biological half life (4hrs) and dosing frequency more than once in a day 
makes Aceclofenac an ideal candidate for sustained release. However, its adverse effects are seen in patients 
with active or suspected peptic or duodenal ulcer or history recurrent peptic ulcer or who have GI bleeding or 
bleeding disorders. These concerns led to the preparation of Aceclofenac loaded microspheres for the controlled 
release application using natural polymers.  
              In  the  present  study,  Aceclofenac  microspheres are prepared and evaluated using “Box-Behnken 
experimental design”. The study also aims to statistically optimize the formulation parameters of Aceclofenac 
loaded microspheres for maximum entrapment and controlled release. Variables selected were Aceclofenac 
concentration (X1), glutraldehyde concentration (X2) and chitosan concentration (X3). The response variables 
were the mean diameter (Y1) and the entrapment efficiency (Y2) of the microspheres. The levels for these 
variables were determined from the preliminary trials.  
             Factorial design is nothing but a guideline for experimental plan. For a given number of factors, it gives 
number of experiments to be carried out as well as quantities of variable ingredients to be used in the 
experiments. The basic principle is to change level of one factor keeping the levels of other constant. Once the 
design is framed, products are made according to these formulas. The responses obtained from the products are 
analyzed for the main and interaction effects. The results are analyzed for the significance of effects too. 
          In  factorial  designs,  the  optimization  procedure is facilitated by fitting of an empirical polynomial 
equation to the experimental results. The equation constructed from a 2n factorial experiment will have 2n 
terms. 
M. Mothilal et al. / International Journal of Pharma Sciences and Research (IJPSR)
ISSN : 0975-9492 Vol 3 No 2 February 2012 305     The generalized expression is,   
 Y= B0 + B1X1 + B2X2 + B3X3 + B12X1X2 + B13X1X3 + B23X2X3 + B123X1X2X3. 
Here, Y is the measured response and X1 is the level of ith factor. Bi, Bij, Bijk, etc. represent coefficients of 
factors and interaction terms computed from the responses of the experimental formulation. From eight 
formulations, eight responses or eight values of Y are obtained. If the low levels of all zero, all the terms except 
B0 become zero. 
Materials 
           Aceclofenac was obtained as a gift sample from Micro Labs, Puducherry, India. Chitosan was purchased 
from High Media Laboratories Pvt. Ltd. , Mumbai. Glutraldehyde and acetic acid were purchased from Ranbaxy 
Fine Chemicals Ltd, New Delhi. Paraffin oil and n-Hexane were purchased from RFCL limited. Span-80 was 
purchased from Rolex Laboratory Reagent.  
Method  
Preparation of Aceclofenac Microspheres 
            Chitosan solution of varying concentration (1, 2 and 3%w/v) was prepared in 1%w/v acetic acid. 
Aceclofenac (5, 10 and 15mg) was dispersed in 5ml of this solution and mix well. This mixture was added 
drop wise using a 22-gauge hypodermic syringe to the oily phase (100ml of paraffin oil containing 2%w/v 
of sorbiton sesquioelate) kept in stirring. Stirring was continued for 5min after the complete addition of 
chitosan solution to oil. Later 2.5ml of glutaraldehyde solution was added to the mixture with continues 
stirring at 250rpm. Glutaraldehyde (2.5ml) was added twice to the mixture, once after 1hr and then 2hrs 
with continues stirring. Stirring was stopped after 1hr of the final addition of glutaraldehyde. All batches 
were prepared atleast three times. The microspheres were isolated by vacuum filtration (0.45µm, PFTE 
membrane filter), washed with equal volume of n-hexane and freeze dried (Heto power dry LL 3000 
lyophilizer). The full factorial design and layout with coded variables are shown in table4 [Akbuja, J., 
1996]. 
       Experimental Design 
  A Box-Behnken experimental design was employed to statistically optimize the 
formulation parameters of ACE microsphere preparation for maximum entrapment, optimum diameter and 
controlled release. The Box-Behnken design was specifically selected science it requires fewer treatment 
combinations than other design   in cases involving 3 or 4 factors. The box-Behnken design is also rotable 
and contains statistical “missing corners” which may be useful when the experimenter is trying to avoid 
combind factor extremes. This property prevents a potential loss of data in those cases. Generation and 
evaluation of the statistical experimental design eas perfomed with the STATEASE, design expert, 7.0.3. a 
design matrix comprising of 17 experimental runs was conducted. An interactive second order polynomial 
was utilized to evaluate both the response variables: 
Y= B0 + B1X1 + B2X2 + B3X3 + B12X1X2 + B13X1X3 + B23X2X3 + B1X1
2 + B2X2
2 + B3X3
2. 
Where B0-B3 are regression coefficients, X1-X3 are the factors studied and Y is the measured response 
associated with each factor level combination.  
Physical characterization of microspheres 
           Particle size analysis: 
              Samples of the microparticles were analyzed for particle size by optical microscopy method using 
a calibrated stage micrometer for randomly selected samples of all the formulations. 
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         For determination of drug content 100mg of aceclofenac microspheres was powdered 50mg of powder was 
transferred to 100ml volumetric flask, dissolved in water and made volume to 100ml. The solution was kept for 
1hr with occasional shaking and filtered through the whatman filter paper. The filtrate was collected and diluted 
with to sufficient amount of distilled water maintaining concentration of the drug with in the standard plot 
range. The diluted solution was analyzed for the aceclofenac content by UV-spectrophotometer (UV-1700 
Shimadzu Corporation) at 274nm. 
Drug loading efficiency: (DLE) 
       DLE was studied by dissolving microspheres in distilled water for 24hrs. The amount of drug loaded was 
determined by spectrophotometrically at 274nm. 
                                                  DLE=                 Experiential drug content               ×100    
                                                                              Theoretical drug content. 
 In vitro drug release 
           In vitro drug release studies were carried out for prepared microspheres. Accurately weighed 100mg of 
microspheres was taken for dissolution studies. Dissolution was carried out using USP apparatus type-2 (Paddle 
method) maintained at 37
⁰c, 100 rpm; in phosphate buffer P
H 7.4. Aliquots of sample were withdrawn at 
predetermined intervals of time and analyzed for drug release for measuring the absorbance 
spectrophotometrically at 274nm.  
SEM analysis 
        Scanning electron microscopy was used to examine the surface morphology of microspheres. Dried 
microspheres were mounted onto stubs by using double-sided adhesive tape and vacuum coated with gold film 
using sputter coater and observed under scanning electron microscope [Costa, P., 2001].   
Results and discussion 
In the present work controlled release microspheres of Aceclofenac were formulated using chitosan 
polymer by ionic cross-linking technique.  
For response surface methodology involving Box-Behnken experimental design, a total number of 17 
experiments were performed for three factors at three levels each. Table No. 1 summarizes the experimental 
runs, their factor combinations and the levels of experimental units used in the study as well as the entrapment 
and mean diameter obtainted for each factor combination. In order to determine the maximum entrapment 
mathematical relationships were generated. For estimation of coefficients the least square regression method 
was used. 
A suitable polynomial equation was selected based on several statistical parameters. The resultant 
equations for both responses Y1 & Y2 are 
    
MD (Y1) = 17.66+0.36X1-0.80X2+1.92X3-0.41X1X2+0.69X1X3-2.98X2X3+0.85X1
2 -2.92X2
2-1.54X3
2 
EE(Y2)=77.25+1.62X1-5.10X2+8.88X3+0.035X1X2+1.30X2X3-0.087X2X3-3.98X1
2 -3.63X2
2-1.78X3
2. 
 
PRESS is a measure of the fit the model to the points in the design. The smaller the PRESS statistic is, 
the better the model fits to the data points. From the p-values in table No.1 it was concluded that cross product 
contribution (2FI) was not significant indicating the absence of interaction effect. 
EE and MD of STP microspheres showed R
2 values of above equations to be 0.9317 &0.9892 (Table 
No. 2) respectively; indicating  good fit and it could be concluded that second order model adequately 
approximated the true surface. For estimation of significance of the model, the ANOVA was applied using 5% 
significance level. 
All the formulations prepared with in the experimental design yielded smooth spherical microspheres 
with size in the range of 10.01- 21.11µm. ACE at medium level (X1,0), Glutaraldehyde at low level (X2,-1) and 
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diameter. 
In table No.3, factor effects of Box-Behnken model associated p-values and standardized mead effects 
(SME) values for both responses are also presented. A positive sign indicates synergistic effect and negative 
sign represents an antagonistic effect of the factor on the selected response. The large SME indicated that the 
CC was the main influential factor on the drug entrapment as well of size of microspheres. This was further 
investigated by the study of ANOVA. In three dimensional plot effects of independent variables were presented 
by keeping one factor at constant level. 
The particle size of microspheres can also be increased by increase in the concentration of polymer by 
increasing the crosslinking and matrix density of microspheres.  
ACE concentration (X1) also exerted positive effect on both responses but it was not significant at 
higher concentration of the drug. Although further increase in drug concentration might be increasing the 
viscosity of the droplet, it does not result in significant change in MD of microspheres. 
Glutaraldehyde exerted a negative effect on the entrapment efficiency & negative effect on MD of 
microspheres as indicated by sign of coefficients in table No.3. 
Using the model generated with both responses maximum entrapment of 85.46% and optimum 
diameter 7.29µm of formulation (ACE11) was identified. 
In vitro release behavior of microspheres exhibiting maximum entrapment (ACE11) and pure drug 
(ACE) was investigated in phosphate buffer (P
H 7.4) for 24 hrs. An intial burst of 19.24% was observed in the 
first hour due to the drug located on or near the surface of microspheres. At the end of the 6
th hour the 
microspheres showed  40.23%drug release. The release rates were analysed by least square regression method. 
The release models such as First order model, Higuchi model and Ritger-peppas empirical model were applied 
to the released data. 
Figure 1: SEM of ACE11 Chitosan microspheres 
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Fig.3  3D plot for the effect of selected variables (X2, X3) on mean diameterof microspheres 
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Fig.5  Intraction plot for the effect of selected variables (X1, X3) on entrapment efficiency of microspheres 
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Fig.7  3D  plot for the effect of selected variables (X1, X2) on entrapment efficiency of microspheres 
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Table No. 1 Box-Behnken experimental design layout with coded levels and actual values of variables 
 
Formulation code  X1 
ACE(mg) 
X2 
Glutaraldehyde 
(%w/v) 
X3 
Chitosan(%w/v) 
Y1 
MD(µm) 
Y2 
EE (%) 
ACE1 1.00    0  1.00  21.10  84.45 
ACE 2  0.00  -1.00  -1.00  10.42  67.66 
ACE 3  0.00  1.00  1.00  10  75.84 
ACE 4  -1.00  0.00  -1.00  14.31  61.12 
ACE 5  0.00  1.00  -1.00  13.35  58.39 
ACE 6  1.00  1.00  0.00  15  64.72 
ACE 7  1.00  0.00  -1.00  14.55  63.94 
ACE 8  0.00  0.00  0.00  17.84  76.98 
ACE 9  -1.00  0.00  1.00  18  76.43 
ACE 10  1.00  -1.00  0.00  15.98  75.61 
ACE 11  0.00  -1.00  1.00  7.29  85.46 
ACE 12  0.00  0.00  0.00  17.79  77.58 
ACE 13  -1.00  -1.00  0.00  15.36  74.62 
ACE 14  0.00  0.00  0.00  17.46  77.13 
ACE 15  0.00  0.00  0.00  17.74  77.61 
ACE 16  -1.00  1.00  0.00  16.26  63.59 
ACE 17  0.00  0.00  0.00  17.45  76.94 
 
Table No. 2 Summary of results of a) model analysis b) lack of fit c) R-square analysis for measured responses 
Source MD  (Y1) EE  (Y2) 
Sum of sqares  P>F  Sum of squares  P>F 
a)Model analysis 
Mean vs. total 
Linear vs. mwan 
2FI vs. meam 
Quadratic vs. 2FI 
Cubic vs. quadratic 
Residual 
Total 
 
4328.03 
35.69 
 38.14 
49.62 
8.76 
0.14 
4460.38 
 
- 
0.2373 
0.1544 
0.0030 
0.0005 
- 
- 
 
90165.72 
860.55 
6.80 
149.60 
10.69 
0.42 
91193.78 
 
- 
<0.0001 
0.9331 
0.0002 
0.0027 
- 
- 
b) Lack of fit 
Linear 
2FI 
Quadratic 
Cubic 
Pure error 
 
96.52 
58.38 
8.76 
0.00 
0.14 
 
<0.0001 
<0.0001 
0.0005 
- 
 
167.09 
160.29 
10.69 
0.42 
 
<0.0001 
<0.0001 
0.0027 
- 
c) R-Square analysis  Adjusted R
2  PRESS Adjusted  R
2 PRESS 
Linear 
2FI 
Quadratic 
Cubic 
0.1011 
0.2926 
0.8464 
0.9958 
188.26 
242.15 
140.31 
- 
0.7995 
0.7499 
0.9753 
0.9984 
256.02 
432.38 
171.75 
- 
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values 
 Y 1 (MD)  Y2 (EE) 
Coefficients Full 
Model 
Reduced 
Model 
p-value SME  Full 
Model 
Reduced 
Model 
p-value SME 
bo  17.66 18.02 0.0026  0.51  77.25 77.25  <0.0001  0.56 
b1  0.36 -  0.4074  0.40  1.62  1.62  0.0083  0.45 
b2  -0.80 -0.80  0.0875  0.40  -5.10 -5.10  <0.0001  0.45 
b3  1.95 1.95  0.0019  0.40  8.88 8.88  <0.0001  0.45 
b1b2  -0.41  -  0.5016  0.57  0.035  -  0.9573  0.63 
b2b3  0.69 -  0.2682  0.57  1.30 -  0.0780  0.63 
b1b3  -2.98 -2.98  0.0012  0.57  -0.087  -  0.8935  0.63 
b1
2  0.88 -  0.1600  0.56  -3.98  -3.38  0.0003  0.61 
b2
2  -2.95 -2.90  0.0011  0.56  -3.63 -3.36  0.0006  0.61 
b3
2  -1.51 -1.46  0.0303  0.56  -1.78 -1.78  0.0230  0.61 
R
2  0.9317 0.8810  -  -  0.9892 0.9826     
Significance 0.0004 0.0006  -  -  0.0027 0.0001  -  - 
F 10.61  16.29  -  -  71.16  94.0  -  - 
  
In vitro dissolution profile 
Table No.4 In vitro release profiles of ACE from ACE11 microspheres 
     S.No  TIME(hrs)  %CDR 
1 0  0 
2 1 19.24 
3 2 22.79 
4 3 28.62 
5 4 36.04 
6 5 38.67 
7 6 40.23 
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                  Fig8 In vitro release profiles of ACE from ACE11 microspheres 
 
Table No. 6 Release behavior of ACE from ACE11 in phosphate buffer (P
H 7.4) 
Release Kinetics  Correlation Coefficient (R
2) 
First order equation  0.920 
Higuchi (diffusion) co-efficient  0.989 
Korsmeyer-peppas equation  0.961 
 
CONCLUSION AND SUMMARY 
         In present study, “Box-Behnken experimental design” was employed to statistically optimize the 
formulation parameters (by changing the drug, polymer, cross linking agent concentration) of Aceclofenac 
loaded chitosan microspheres for maximum entrapment and controlled release. 
         The optimized formulation for Aceclofenac was obtained with 2%ACE concentration, 2%w/v 
Glutaraldehydre concentration and 3%w/v Chitosan concentration using response surface methodology based on 
Box-Behnken design. It was found that the observed responses were close to the predicted values for the 
optimized formulation. In conclusion NSAID controlled release delivery system utilizing natural polymer i.e. 
chitosan for Aceclofenac was successfully developed. Further parameters for dosage form designing can be 
identified for optimum formulation in terms of desirable long-term stability and to study the therapeutic effects 
of these particles In vivo.    
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